Swiss National Bank’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.66M Buy
9,700
+2,700
+39% +$342K ﹤0.01% 2028
2026
Q1
$665K Hold
7,000
﹤0.01% 2235
2025
Q4
$1.15M Hold
7,000
﹤0.01% 2114
2025
Q3
$723K Buy
7,000
+700
+11% +$68.6K ﹤0.01% 2251
2025
Q2
$784K Buy
+6,300
New +$814K ﹤0.01% 2232
2023
Q4
Sell
-5,207
Closed -$158K 2585
2023
Q3
$158K Hold
5,207
﹤0.01% 2606
2023
Q2
$329K Buy
5,207
+532
+11% +$45.6K ﹤0.01% 2590
2023
Q1
$708K Sell
4,675
-554
-11% -$112K ﹤0.01% 2420
2022
Q4
$1.49M Buy
+5,229
New +$1M ﹤0.01% 2079

Other funds holding NUTX

Swiss National Bank's NUTX Position: Q2 2026 in Review

Swiss National Bank increased its Nutex Health (NUTX) stake by 39% in Q2 2026, buying an estimated $342K and bringing the position to 9,700 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #2028.

Swiss National Bank first reported a position in NUTX in Q4 2022 and has held it in 9 quarters since. 68 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Swiss National Bank held 9,700 shares of Nutex Health worth $1.66M as of Q2 2026.
  • Swiss National Bank bought 2,700 Nutex Health shares in Q2 2026, an estimated $342K.
  • Nutex Health made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #2028 holding.
  • Swiss National Bank first reported a position in Nutex Health in Q4 2022 and has held it in 9 quarters since.
  • 68 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.